Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Investigating the role of the F-box protein FBX045 in DNA damage-induced apoptosis in tumor cells

EF 2008-09

Résumé
p53 is a tumor suppressor gene that is commonly mutated in cancer. This transcription factor plays a role in determining the fate of a cell following DNA damage, whether it is cell death, or cell cycle arrest and DNA repair. In order to further our understanding of the complex p53 signaling network, the model organism Caenorhabditis elegans has been used because it has a single ancestral p53 family member (CEP-1) and is an excellent organism to do genetic tests on. Through our work in C. elegans, it was discovered that CEP-1 was regulated by an F-box protein called FSN-1. The goal of my research is to determine whether FSN-1 has the same function in human cells as it does in the worm. The FSN-1 orthologue in human cells is called FBX045. I will be determining whether FBX045 knockdowns affect p53 target gene expression, whether exposure to DNA-damaging agents regulate FBX045 mRNA and protein levels, and determine what proteins FBX045 binds to by using a stably transfected cell line expressing FLAG-FBX045. After the substrates of FBX045 are identified by immunoprecipitation, we will be knocking them down to determine their role in DNA damage-induced apoptosis. Lastly, we can use C. elegans mutant worms that are FSN-1 depleted and do a genome-wide screen using RNA interference libraries to determine which genes interact with FSN-1 to induce apoptosis following DNA damage. This research will help elucidate the pathways that regulate p53 activity, will provide insight on p53 deregulation during carcinogenesis, and hopefully provide a novel target for cancer chemotherapy.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184666
Name
Lau Annette
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the role of the F-box protein FBX045 in DNA damage-induced apoptosis in tumor cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Apoptosis; Dna Damage; P53 Family
Abstract
p53 is a tumor suppressor gene that is commonly mutated in cancer. This transcription factor plays a role in determining the fate of a cell following DNA damage, whether it is cell death, or cell cycle arrest and DNA repair. In order to further our understanding of the complex p53 signaling network, the model organism Caenorhabditis elegans has been used because it has a single ancestral p53 family member (CEP-1) and is an excellent organism to do genetic tests on. Through our work in C. elegans, it was discovered that CEP-1 was regulated by an F-box protein called FSN-1. The goal of my research is to determine whether FSN-1 has the same function in human cells as it does in the worm. The FSN-1 orthologue in human cells is called FBX045. I will be determining whether FBX045 knockdowns affect p53 target gene expression, whether exposure to DNA-damaging agents regulate FBX045 mRNA and protein levels, and determine what proteins FBX045 binds to by using a stably transfected cell line expressing FLAG-FBX045. After the substrates of FBX045 are identified by immunoprecipitation, we will be knocking them down to determine their role in DNA damage-induced apoptosis. Lastly, we can use C. elegans mutant worms that are FSN-1 depleted and do a genome-wide screen using RNA interference libraries to determine which genes interact with FSN-1 to induce apoptosis following DNA damage. This research will help elucidate the pathways that regulate p53 activity, will provide insight on p53 deregulation during carcinogenesis, and hopefully provide a novel target for cancer chemotherapy.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lau, Annette
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~